← The SEC Ephemeris: the whole map
Ardelyx, Inc. tenapanor hydrochloride
In the graph: all 16 documents (179 pages).
- Application
- NDA 213931
- Ticker
- ARDX
- Product
- tenapanor hydrochloride
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- July 28, 2021
From FDA letters and SEC filings. Not investment or medical advice.